-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
9 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$24.81 M
Alnylam Pharmaceuticals, Inc. Insider Transactions
Alnylam Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
| Sell | 7,093 @ $261.00 | $1.85 M | 73,441 | 07/11/2024 | 07/12/2024 | ||
|
SCHULMAN AMY W
Director |
Sell | 8,500 @ $240.00 | $2.04 M | 8,436 | 06/25/2024 | 06/27/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 78 @ $221.71 | $17,293 | 17,634 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 17 @ $224.17 | $3,811 | 17,617 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 24 @ $225.55 | $5,413 | 17,593 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 45 @ $226.82 | $10,207 | 17,548 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 169 @ $228.30 | $38,583 | 17,379 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 348 @ $229.06 | $79,713 | 17,031 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 398 @ $229.93 | $91,512 | 16,633 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 129 @ $231.59 | $29,875 | 16,504 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 283 @ $232.54 | $65,809 | 16,221 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 151 @ $233.53 | $35,263 | 16,070 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 242 @ $234.66 | $56,788 | 15,828 | 06/25/2024 | 06/26/2024 | |
|
Garg Pushkal
CMO & EVP Dev & Med Affairs |
Sell | 219 @ $235.19 | $51,507 | 15,609 | 06/25/2024 | 06/26/2024 | |
| Sell | 308 @ $221.71 | $68,287 | 88,527 | 06/25/2024 | 06/26/2024 | ||
| Sell | 66 @ $224.17 | $14,795 | 88,461 | 06/25/2024 | 06/26/2024 | ||
| Sell | 93 @ $225.55 | $20,976 | 88,368 | 06/25/2024 | 06/26/2024 | ||
| Sell | 177 @ $226.82 | $40,147 | 88,191 | 06/25/2024 | 06/26/2024 | ||
| Sell | 666 @ $228.30 | $152,048 | 87,525 | 06/25/2024 | 06/26/2024 | ||
| Sell | 1,374 @ $229.06 | $314,728 | 86,151 | 06/25/2024 | 06/26/2024 |
Alnylam Pharmaceuticals, Inc. Frequently Asked Questions
-
Who is on Alnylam Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at Alnylam Pharmaceuticals, Inc. includes Franchini Indrani Lall, Greenstreet Yvonne, Tanguler Tolga, Poulton Jeffrey V., Garg Pushkal, SHARP PHILLIP A, SCHULMAN AMY W, PYOTT DAVID E I, Fitzgerald Kevin Joseph.
-
How much insider selling is happening at Alnylam Pharmaceuticals, Inc.?
Insiders have sold a total of 131,410 Alnylam Pharmaceuticals, Inc. shares in the last 12 months for a total of 24.81 M sold.
-
Which Alnylam Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold Alnylam Pharmaceuticals, Inc. shares in the last 12 months: Franchini Indrani Lall ($323,145), Greenstreet Yvonne ($5.26 M), Tanguler Tolga ($597,949), Poulton Jeffrey V. ($608,991), Garg Pushkal ($768,584), SHARP PHILLIP A ($4.54 M), SCHULMAN AMY W ($5.26 M), PYOTT DAVID E I ($7.16 M), Fitzgerald Kevin Joseph ($276,731),